Skip to main content

Advertisement

Log in

Clinical improvement of membranous nephropathy after endoscopic resection of double early gastrointestinal cancers

  • Case Report
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

A-52-year-old man presented to our hospital with nephrotic syndrome caused by membranous nephropathy. Early gastric adenocarcinoma confined to the submucosa, and well-differentiated adenocarcinoma in a sigmoid adenoma were detected by screening endoscopy. Two years after complete endoscopic resection of these tumors, the estimated 24-h urinary protein excretion decreased, and serum total protein and albumin returned to their normal levels although he had no immunosuppressive therapy. Thus, this case was considered to be a case of secondary membranous nephropathy to cancer, although whether the pathogenesis was due to circulating or in situ immune complexes is unknown. The suspected antigen component of this immune complex can include carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9). In our patient, however, serum CEA and CA19-9 were within normal values during the clinical course, and detected cancers were early stage and very small. Recently, the existence of anti-mucin 1 (MUC1) antibodies before carcinogenesis and their usefulness for early detection of cancer were reported. We tried to stain tumors and glomeruli for MUC1 but, although we had positive findings in both tumors but not in glomeruli, the role of MUC1 in the pathogenesis of membranous nephropathy is unknown. To the best of our knowledge, paraneoplastic nephrosis caused by double early cancers expressing MUC1 in the gastrointestinal tract has not been previously reported.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Jefferson JJ, Couser WG. Therapy of membranous nephropathy associated with malignancy and secondary causes. Semin Nephrol. 2003;23:400–5.

    Article  PubMed  Google Scholar 

  2. Hoshino J, Hara S, Ubara Y, Takaya H, Suwabe T, Sawa N, et al. Distribution of IgG subclasses in a biopsy specimen showing membranous nephropathy with anti-glomerular basement membrane glomerulonephritis: an uncharacteristically good outcome with corticosteroid therapy. Am J Kidney Dis. 2005;45:e67–72.

    Article  PubMed  Google Scholar 

  3. Kim HO, Hwang SI, Yoo CH, Kim H. Preoperative colonoscopy for patients with gastric adenocarcinoma. J Gastroenterol Hepatol. 2009;24:1740–4.

    Article  PubMed  Google Scholar 

  4. Bae JS, Lee JH, Ryu KW, Kim YW, Bae JM. Characteristics of synchronous cancers in gastric cancer patients. Cancer Res Treat. 2006;38:25–9.

    Article  PubMed  Google Scholar 

  5. Pascal RR, Slovin SF. Tumor directed antibody and carcinoembryonic antigen in the glomeruli of a patient with gastric carcinoma. Hum Pathol. 1980;11:679–82.

    Article  PubMed  CAS  Google Scholar 

  6. Wakashin M, Wakashin Y, Iesato K, Ueda S, Mori Y, Tsuchida H, et al. Association of gastric cancer and nephrotic syndrome. An immunologic study in three patients. Gastroenterology. 1980;78:749–56.

    PubMed  CAS  Google Scholar 

  7. Row PG, Cameron JS, Turner, Evans DJ, White RH, Ogg CS, et al. Membranous nephropathy. Long-term follow-up and association with neoplasia. Q J Med. 1975;44:207–39.

    PubMed  CAS  Google Scholar 

  8. Couser WG, Wagonfeld JB, Spargo BH, Lewis EJ. Glomerular deposition of tumor antigen in membranous nephropathy associated with colonic carcinoma. Am J Med. 1974;57:962–70.

    Article  PubMed  CAS  Google Scholar 

  9. Braymann M, Thathiah A, Carson DD. MUC1: a multifunctional cell surface component of reproductive tissue epithelia. Reprod Biol Endocrinol. 2004;2:4.

    Article  Google Scholar 

  10. Leroy X, Copin MC, Devisme L, Buisine MP, Aubert JP, Gosselin B, et al. Expression of human mucin genes in normal kidney and renal cell carcinoma. Histopathology. 2002;40:450–7.

    Article  PubMed  CAS  Google Scholar 

  11. Leroy X, Devisme L, Buisine MP, Copin MC, Aubert S, Gosselin B, et al. Expression of human mucin genes during normal and abnormal renal development. Am J Clin Pathol. 2003;120:544–50.

    Article  PubMed  CAS  Google Scholar 

  12. Pinheiro SP, Hankinson SE, Tworoger SS, Rosner BA, McKolanis JR, Finn OJ, et al. Anti-MUC1 antibodies and ovarian cancer risk: prospective data from the Nurses’ Health Studies. Cancer Epidemiol Biomarkers Prev. 2010;19:1595–601.

    Article  PubMed  CAS  Google Scholar 

  13. Wandall HH, Blixt O, Tarp MA, Pedersen JW, Bennette EP, Mandel U, et al. Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes. Cancer Res. 2010;70:1306–13.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We are grateful to Dr. Masahisa Kyogoku for discussions on pathology and helpful suggestions.

Conflict of interest

This study received no financial support and none of the authors has any conflict of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Satoshi Matsui.

About this article

Cite this article

Matsui, S., Tsuji, H., Takimoto, Y. et al. Clinical improvement of membranous nephropathy after endoscopic resection of double early gastrointestinal cancers. Clin Exp Nephrol 15, 285–288 (2011). https://doi.org/10.1007/s10157-010-0389-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-010-0389-6

Keywords

Navigation